Shamburg News · 8-K filed Nov 12, 2026, 7:19 AM EST

Twist Bioscience Reports Fiscal 2026 Revenue of $459.4 Million and Net Loss of $130.2 Million

TWST · Twist Bioscience Corp

  • Earnings
  • Materiality: high

Twist Bioscience Corporation reported fiscal 2026 revenue of $459.4 million, up from $376.6 million in fiscal 2025, and a net loss of $130.2 million, or $2.08 per diluted share, compared with a net loss of $77.7 million, or $1.30 per diluted share, a year earlier. Fourth-quarter fiscal 2026 revenue was $126.6 million, compared with $99.0 million in the prior-year quarter. The company guided fiscal 2027 total revenue to approximately $550 million to $560 million.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Item 2.02, accession 0001581280-26-000053.

Written from the filing by Shamburg Markets. Figures are as reported by the company.